SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:gup.ub.gu.se/56718"
 

Search: id:"swepub:oai:gup.ub.gu.se/56718" > A multicentre, retr...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden.

Lindblom, Bertil, 1951 (author)
Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för klinisk neurovetenskap och rehabilitering,Institute of Neuroscience and Physiology, Department of Clinical Neuroscience and Rehabilitation
Nordmann, Jean-Philippe (author)
Sellem, Eric (author)
show more...
Chen, Enping (author)
Karolinska Institutet
Gold, R (author)
Polland, Werner (author)
Williamson, W (author)
Buchholz, Patricia (author)
Walt, John G (author)
Groleau, Danielle (author)
Curry, Alistair (author)
Evans, Stacy J (author)
show less...
 (creator_code:org_t)
2005-12-08
2006
English.
In: Acta ophthalmologica Scandinavica. - : Wiley. - 1395-3907. ; 84:1, s. 74-83
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • PURPOSE: To assess resource utilization and costs associated with glaucoma management in France and Sweden. METHODS: A total of 267 patient records (121 in France, 146 in Sweden) with diagnoses of primary open-angle glaucoma (POAG) and ocular hypertension (OH), treated medically, were reviewed for a 2-year period (beginning during 1997-99) for relevant clinical and resource utilization data. Economic data were applied to estimate treatment costs. RESULTS: The annual cost of treating glaucoma was estimated at SEK5305 (531 euro )/patient in Sweden and 390 euro/patient in France. In both countries, medication costs comprised about half of the total costs. Surgical procedures and hospitalizations represented greater proportions of total cost in France (7.0% and 9.6%, respectively) than in Sweden (3.7% and 0.6%, respectively). CONCLUSION: Medication costs represent a high proportion of total treatment costs. These findings highlight the relative importance of medical therapy and of assessing the cost-effectiveness of medications in glaucoma.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Oftalmologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Ophthalmology (hsv//eng)

Keyword

Aged
Antihypertensive Agents
economics
Cost-Benefit Analysis
Drug Costs
Female
France
Glaucoma
Open-Angle
economics
therapy
Health Care Costs
Health Resources
economics
utilization
Humans
Intraocular Pressure
Male
Ocular Hypertension
economics
therapy
Ophthalmologic Surgical Procedures
economics
Retrospective Studies
Sweden

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view